CDKN1A and neoplasm: In the case of p21, differences in metastasis-free survival were found between the p21-positive and p21-negative groups (p = 0.018) that were not apparent for tumor-specific mortality (p = 0.269) or overall survival (p = 0.316) (Figure 3).